South Korea Assisted Reproductive Technology Market PPT 2024: Size, Growth, Demand and Forecast till 2032
                     South Korea Assisted 
Reproductive Technology 
Market Research and 
Forecast Report 2024-
2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
IMARC Group is  a g lobal  management  consul t ing f i rm that  he lps the wor ld ’s  most  ambi t ious 
changemakers  to create a las t ing impact .  Across the s ix  major  cont inents  and 100+ count r ies ,  we 
work a longside our  bus iness par tners  as one team wi th  a common ambi t ion to achieve unparal le led 
resul ts ,  gain a compet i t ive edge,  and t ransform indust r ies .  IMARC Group excels  in  unders tanding 
i ts  c l ients ’  bus iness pr ior i t ies  and del iver ing ta i lored solut ions that  dr ive meaningfu l  outcomes.  Our 
c l ient  base spans over  3,000 organizat ions in  the pr ivate,  publ ic ,  and soc ia l  sectors ,  ranging f rom 
high-growth s tar tups to For tune 500 companies.
We prov ide a comprehensive sui te of  market  entry  and expansion serv ices.  Our of fer ings inc lude 
thorough market  assessment ,  feas ib i l i ty  s tudies,  company incorporat ion ass is tance,  fac tory  setup 
suppor t ,  regulatory  approvals and l icens ing navigat ion,  branding,  market ing and sales st rategies,  
compet i t ive landscape and benchmark ing analyses,  pr ic ing and cost  research,  and procurement  
research.  These serv ices are des igned to ass is t  companies in  evaluat ing market  oppor tuni t ies ,  
set t ing up new ent i t ies ,  navigat ing regulatory landscapes,  boost ing brand v is ib i l i ty ,  analyz ing 
compet i tors,  and opt imiz ing procurement  s t rategies.
A c c o r d i n g  t o  t h e  l a t e s t  r e p o r t  b y  I M A R C  G r o u p ,  t i t l e d  " S o u t h  K o r e a  A s s i s t e d  R e p r o d u c t i v e  
T e c h n o l o g y  M a r k e t :  I n d u s t r y  T r e n d s ,  S h a r e ,  S i z e ,  G r o w t h ,  O p p o r t u n i t y  a n d  F o r e c a s t  2 0 2 4 -
2 0 3 2 , "  t h e  S o u t h  K o r e a  a s s i s t e d  r e p r o d u c t i v e  t e c h n o l o g y  m a r k e t  s i z e  i s  p r o j e c t e d  t o  e x h i b i t  a  
g r o w t h  r a t e  ( C A G R )  o f  7 . 4 0 %  d u r i n g  2 0 2 4 - 2 0 3 2 .
T h e  r i s i n g  d e m a n d  f o r  a s s i s t e d  r e p r o d u c t i v e  t e c h n o l o g y  ( A R T )  a m o n g  t h e  a g i n g  p o p u l a t i o n ,  a s  
Report t h e y  a r e  f a c i n g  i n f e r t i l i t y  i s s u e s ,  i s  i m p e l l i n g  t h e  m a r k e t  g r o w t h .  T h e r e  i s  a n  i n c r e a s e  i n  t h e  d e m a n d  f o r  A R T  s e r v i c e s  a s  S o u t h  K o r e a n s  d e l a y  m a r r i a g e  a n d  c h i l d b e a r i n g  d u e  t o  c a r e e r  a n d  
f i n a n c i a l  c o n s i d e r a t i o n s .  A d d i t i o n a l l y ,  S o u t h  K o r e a ' s  a d v a n c e d  h e a l t h c a r e  i n f r a s t r u c t u r e  s u p p o r t s  
Highlight and t h e  g r o w t h  o f  t h e  A R T  m a r k e t .  T h e  c o u n t r y  h a s  c u t t i n g - e d g e  m e d i c a l  t e c h n o l o g y  a n d  s k i l l e d  p r o f e s s i o n a l s ,  e n s u r i n g  h i g h  s u c c e s s  r a t e s  f o r  p r o c e d u r e s ,  s u c h  a s  i n  v i t r o  f e r t i l i z a t i o n  ( I V F )  a n d  
e m b r y o  t r a n s f e r .  F u r t h e r m o r e ,  S o u t h  K o r e a  i s  h o m e  t o  s o m e  o f  t h e  w o r l d ' s  l e a d i n g  f e r t i l i t y  c l i n i c s  
a n d  r e s e a r c h  i n s t i t u t i o n s ,  s t a f f e d  b y  h i g h l y  t r a i n e d  a n d  e x p e r i e n c e d  p r o f e s s i o n a l s .  T h e s e  e x p e r t s  
Description e m p l o y  t h e  l a t e s t  t e c h n i q u e s  a n d  p r o t o c o l s  t o  o p t i m i z e  t r e a t m e n t  o u t c o m e s .  B e s i d e s  t h i s ,  t h e  
i n t e g r a t i o n  o f  t e c h n o l o g y  i n t o  A R T  p r a c t i c e s  i s  l e a d i n g  t o  i n n o v a t i o n s ,  s u c h  a s  p r e i m p l a n t a t i o n  
g e n e t i c  t e s t i n g  ( P G T )  a n d  e m b r y o  c r y o p r e s e r v a t i o n ,  w h i c h  c o n t r i b u t e  t o  h i g h e r  s u c c e s s  r a t e s .  
P G T  a l l o w s  f o r  t h e  s c r e e n i n g  o f  e m b r y o s  f o r  g e n e t i c  a b n o r m a l i t i e s  b e f o r e  i m p l a n t a t i o n ,  r e d u c i n g  
t h e  r i s k  o f  m i s c a r r i a g e  a n d  i n c r e a s i n g  t h e  l i k e l i h o o d  o f  a  s u c c e s s f u l  p r e g n a n c y .
R e q u e s t  f o r  a  P D F  s a m p l e  o f  t h i s  r e p o r t :  
h t t p s : / / w w w . i m a r c g r o u p . c o m / s o u t h - k o r e a - a s s i s t e d - r e p r o d u c t i v e - t e c h n o l o g y - m a r k e t / r e q u e s t s a m p l e
Report Description
South Korea  Ass is ted Reproduct ive  Technology  Market  T rends :
Govern ing  agenc ies  in  the  coun t ry  a re  focus ing  on  address ing  the  low b i r th  ra te  and  encourag ing  popu la t ion  
g rowth .  They  a re  unde r tak ing  f inanc ia l  subs id ies  and  suppor t  p rograms fo r  ART t rea tments .  Fur the rmore ,  Sou th  
Korea 's  s t rong  emphas is  on  research  and  deve lopment  (R&D)  e f fo r t s  i n  the  f ie ld  o f  rep roduc t ive  med ic ine  i s  
lead ing  to  innova t ive  t rea tments  and  improved  ou tcomes,  enhanc ing  the  a t t rac t iveness  o f  t he  marke t .  
Add i t i ona l ly ,  cu l tu ra l  f ac to rs  a l so  con t r ibu te  to  the  marke t ' s  expans ion ,  as  t rad i t iona l  va lues  p lace  h igh  
impor tance  on  fami ly  and  o f f sp r ing ,  d r iv ing  demand fo r  ART among ind iv idua ls  seek ing  to  overcome fe r t i l i t y  
cha l lenges .  The  g row ing  awareness  and  accep tance  o f  ART among the  popu la t ion  because  o f  va r ious  educa t iona l  
campa igns  i s  s t reng then ing  the  marke t  g rowth .  Toge ther ,  t hese  fac to rs  c rea te  a  dynamic  env i ronment  fo r  t he  ART 
marke t  in  the  coun t ry ,  fos te r ing  advancements  in  techno logy ,  access ib i l i t y ,  and  overa l l  i ndus t ry  deve lopment .
View Report  TOC,  F igures  and Tab les :  
h t tps : / /www. imarcgroup.com/south-korea -ass is ted-reproduct ive- technology-market
Product Insights:
• Instrument
o Sperm Separat ion System
o Cryosystem
o Incubator
o Imaging System
o Ovum Aspiration Pump
Report 
o Cabinet
Segmentation o Micromanipulator
o Laser Systems
o Others
• Accessory and Disposable
• Reagents and Media
o Cryopreservat ion Media
o Semen Processing Media
o Ovum Processing Media
o Embryo Culture Media
Type Insights:
• In-Vitro Ferti l ization ( IVF)
o Fresh Donor
Report o Frozen Donor
Segmentation o Fresh Non-Donor
o Frozen Non-Donor
• Artifi cial  Insemination
o Intrauterine Insemination
o Intracervical  Insemination
o Intravaginal  Insemination
o Intratubal  Insemination
End Use Insights:
• Ferti l i ty Cl inics and Other Faci l i t ies
• Hospitals and Others
Regional Insights:
• Seoul Capital  Area
Report 
• Yeongnam (Southeastern Region)
Segmentation • Honam (Southwestern Region)
• Hoseo (Central  Region)
• Others
How has the South Korea assisted reproductive technology market 
performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the South Korea assisted 
reproductive technology market?
What is the breakup of the South Korea assisted reproductive 
technology market on the basis of product?
Key 
What is the breakup of the South Korea assisted reproductive 
technology market on the basis of type?
Questions 
Answered in What is the breakup of the South Korea assisted reproductive technology market on the basis of end use?
the Report What are the various stages in the value chain of the South Korea 
assisted reproductive technology market? 
What are the key driving factors and challenges in the South Korea 
assisted reproductive technology?
What is the structure of the South Korea assisted reproductive 
technology market and who are the key players?
What is the degree of competition in the South Korea assisted 
reproductive technology market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4    S o u t h  K o r e a  A s s i s t e d  R e p r o d u c t i v e  T e c h n o l o g y  M a r k e t  -  I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     M a r k e t  D y n a m i c s
    4 . 3     I n d u s t r y  T r e n d s
    4 . 4     C o m p e t i t i v e  I n t e l l i g e n c e
5    S o u t h  K o r e a  A s s i s t e d  R e p r o d u c t i v e  T e c h n o l o g y  M a r k e t  L a n d s c a p e
    5 . 1     H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
    5 . 2     M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
6    S o u t h  K o r e a  A s s i s t e d  R e p r o d u c t i v e  T e c h n o l o g y  M a r k e t  -  B r e a k u p  b y  P r o d u c t
    6 . 1     I n s t r u m e n t
        6 . 1 . 1  O v e r v i e w
        6 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 1 . 3  M a r k e t  S e g m e n t a t i o n
            6 . 1 . 3 . 1  S p e r m  S e p a r a t i o n  S y s t e m
            6 . 1 . 3 . 2  C r y o s y s t e m
            6 . 1 . 3 . 3  I n c u b a t o r
            6 . 1 . 3 . 4  I m a g i n g  S y s t e m
       
            6 . 1 . 3 . 5  O v u m  A s p i r a t i o n  P u m p
            6 . 1 . 3 . 6  C a b i n e t
            6 . 1 . 3 . 7  M i c r o m a n i p u l a t o r
            6 . 1 . 3 . 8  L a s e r  S y s t e m s
            6 . 1 . 3 . 9  O t h e r s
        6 . 1 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 2     A c c e s s o r y  a n d  D i s p o s a b l e
        6 . 2 . 1  O v e r v i e w
        6 . 2 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 2 . 3  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
    6 . 3     R e a g e n t s  a n d  M e d i a
        6 . 3 . 1  O v e r v i e w
Table of         6 . 3 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        6 . 3 . 3  M a r k e t  S e g m e n t a t i o n
            6 . 3 . 3 . 1  C r y o p r e s e r v a t i o n  M e d i a
Contents             6 . 3 . 3 . 2  S e m e n  P r o c e s s i n g  M e d i a            6 . 3 . 3 . 3  O v u m  P r o c e s s i n g  M e d i a
            6 . 3 . 3 . 4  E m b r y o  C u l t u r e  M e d i a
        6 . 3 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
7    S o u t h  K o r e a  A s s i s t e d  R e p r o d u c t i v e  T e c h n o l o g y  M a r k e t  -  
B r e a k u p  b y  T y p e
    7 . 1     I n - V i t r o  F e r t i l i z a t i o n  ( I V F )
        7 . 1 . 1  O v e r v i e w
        7 . 1 . 2  H i s t o r i c a l  a n d  C u r r e n t  M a r k e t  T r e n d s  ( 2 0 1 8 - 2 0 2 3 )
        7 . 1 . 3  M a r k e t  S e g m e n t a t i o n
            7 . 1 . 3 . 1  F r e s h  D o n o r
            7 . 1 . 3 . 2  F r o z e n  D o n o r
            7 . 1 . 3 . 3  F r e s h  N o n - D o n o r
            7 . 1 . 3 . 4  F r o z e n  N o n - D o n o r
        7 . 1 . 4  M a r k e t  F o r e c a s t  ( 2 0 2 4 - 2 0 3 2 )
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / s o u t h - ko rea - a s s i s t e d - rep ro du c t i v e -
t ech n o lo g y - m a r ke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: